Bookmark and Share

Paul S. Fishman

Paul S. Fishman M.D., Ph.D.

Academic Title: Professor
Primary Appointment: Neurology
Secondary Appointments: Anatomy and Neurobiology, Pharmacology
Additional Title(s): Chief, Neurology Service, Maryland VA Health Care System
Location: VAMC 4A150A
Phone: (410) 605-7000, X6612
Fax: (410) 605-7937

Personal History:

Paul S. Fishman, MD, Ph.D. is a Professor of Neurology, Pharmacology and Neurobiology at the University of Maryland School of Medicine and Chief of Neurology for the Maryland VA Health Care System. He received a doctorate in Neurobiology from Yale University, a medical degree from Johns Hopkins, and trained in Neurology and Cell Biology at Columbia-Presbyterian Medical Center. His clinical and research interests include new therapeutics for Parkinson's Disease, Alzheimer's disease and related neurodegenerative diseases, and he has authored over 100 publications.

As Director of Research for the Department of Neurology he leads a basic research group investigating neuroprotective proteins and stem cell therapeutics for neurodegenerative disease.  As a clinician he established the program for neurotoxin treatment of movement disorders, is the co-founder of the Deep Brain Stimulation program and founded the Alzheimer's Program at the University of Maryland Medical Center. He is listed in Best Doctors in America, is former Chair of the Parkinson's Disease review group for VA Biomedical Research, past Chair of the University of Maryland IRB for supervision of human research and is co-founder of the Medical-Scientific Board of the Alzheimer's Association of Greater Maryland.


  • Medical School: Johns Hopkins University School of Medicine
  • Internship: Johns Hopkins Bayview Medical Center- General Medicine
  • Neurology Residency: Columbia Univ.- New York Presbyterian Medical Center;
    Loyola University Medical Center - Neurology
  • Fellowship: Columbia Univ.- New York Presbyterian Medical Center - Neurology
  • PhD: Yale University
  • Certifications: American Board of Psychiatry and Neurology

Research Interests:

Development of new therapeutics for Alzheimer's disease, Parkinson's disease, ALS and related neurodegenerative diseases and movement disorders. Basic research area of interest is the development of vectors to deliver macromolecular therapies to the brain. Current research interests include designer neurotoxins, novel neuroprotectants against excitotoxicity and neuronal differentiation of stem cells